BioWorld Asia

April 15, 2009

BioXell Shares Plunge on Elocalcitol Miss

BioXell SpA suffered a collapse in its share price following news that its vitamin D3 analogue elocalcitol failed to meet the primary endpoint of a Phase IIb trial in overactive bladder (OAB). (BioWorld International) Read More

ReNeuron Able to Automate Fetal Neural Stem Cell Process

China: Through New Initiatives it Seeks to Boost Innovation

Renovo Confirms it has a Suitor Waiting in the Wings

Amarin Eyes European OK for AMR101 in Huntington's

Study Supplies Missing Piece to Antibiotic Pump Puzzle

Canada and Europe to Work Together on Medicines

Biocortech Initiates Trial of Depression Blood Test

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...

Handshake, businessmen holding dollar sign, lightbulb

Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

BioWorld

A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...